Holen Sie sich die Stockscreener-App
64.30
5.22%
-3.54
Handel nachbörslich:
64.32
0.02
+0.03%
Schlusskurs vom Vortag:
$67.84
Offen:
$68.77
24-Stunden-Volumen:
3.16M
Relative Volume:
2.80
Marktkapitalisierung:
$2.22B
Einnahmen:
$605.49M
Nettoeinkommen (Verlust:
$190.29M
KGV:
13.24
EPS:
4.8571
Netto-Cashflow:
$133.59M
1W Leistung:
-33.77%
1M Leistung:
-43.60%
6M Leistung:
-47.36%
1J Leistung:
-42.33%
1-Tages-Spanne:
$63.24
$69.25
1-Wochen-Bereich:
$63.24
$98.35
52-Wochen-Spanne:
$63.24
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
64.30 | 2.34B | 605.49M | 190.29M | 133.59M | 4.8571 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TransMedics Q1 2026 slides: revenue grows 21% amid profit squeeze - Investing.com India
Earnings call transcript: TransMedics Q1 2026 earnings miss sends stock tumbling - Investing.com
TMDX dips after posting Q1 earnings & revenue miss, margins fall - MSN
TransMedics tumbles after earnings miss - MSN
Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price Decline - Yahoo Finance
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Sell - MarketBeat
TransMedics Group, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:TMDX) 2026-05-08 - Seeking Alpha
TransMedics Group Drops 5.4% After Canaccord Genuity Maintains Buy - AlphaStreet
TransMedics Group Inc (TMDX) Q1 2026 Earnings Call Highlights: S - GuruFocus
TransMedics Group Inc (TMDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Q1 2026 Transmedics Group Inc Earnings Call Transcript - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
TransMedics (TMDX) Faces Significant Drop Amid Market Movements - GuruFocus
TransMedics’ Vitals Are Looking Less Stable, And That Changes Things - Finimize
TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2026 Earnings Call Transcript - Insider Monkey
Normothermic Machine Perfusion Market is Going to Booming Growth 2026-2033 | TransMedics Group Inc, OrganOx - EIN News
My Top 3 Stocks to Buy in May - The Motley Fool
TransMedics Group stock hits 52-week low at 75.58 USD By Investing.com - Investing.com Nigeria
TransMedics: Cheaper, But Still Priced For Perfection (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Given New $124.00 Price Target at Canaccord Genuity Group - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Lowered to $120.00 at TD Cowen - MarketBeat
TransMedics Shares Drop After Oppenheimer Downgrade Following Q1 Miss - marketscreener.com
TransMedics Down Over 25%, On Track for Largest Percent Decrease Since October 2024 -- Data Talk - 富途牛牛
TransMedics Group Stock Watch: Healthcare Growth in Focus - Kalkine Media
Stifel Nicolaus Cuts TransMedics Group (NASDAQ:TMDX) Price Target to $85.00 - MarketBeat
Piper Sandler Issues Pessimistic Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price - MarketBeat
TransMedics Group stock hits 52-week low at 75.58 USD - Investing.com
TransMedics Group Plunges 21.4% Amid Sector-Wide Selling - AlphaStreet
TransMedics Group Stock Tumbles 23% as Profit Hit Overshadows Organ-Transplant Growth - TechStock²
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins Fall - Zacks Investment Research
TransMedics (TMDX) Q1 2026 Earnings Transcript - AOL.com
TransMedics Group (NASDAQ:TMDX) Hits New 12-Month Low on Disappointing Earnings - MarketBeat
Oppenheimer Downgrades TransMedics Group to Market Perform From Outperform - marketscreener.com
Needham & Company LLC Has Lowered Expectations for TransMedics Group (NASDAQ:TMDX) Stock Price - MarketBeat
Oppenheimer downgrades TransMedics stock rating on sentiment concerns By Investing.com - Investing.com Nigeria
TransMedics Group (NASDAQ:TMDX) Downgraded to "Market Perform" Rating by Oppenheimer - MarketBeat
TransMedics Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
TransMedics Group revenue up 21% to USD 173.9M in Q1 2026 - Medical Buyer
Oppenheimer downgrades TransMedics stock rating on sentiment concerns - Investing.com
TransMedics reiterates 2026 revenue guidance of $727M-$757M while targeting CHOPS IDE implementation in early Q3 2026 - MSN
TransMedics Group Q1 2026 Earnings Call Transcript - MarketBeat
TransMedics Q1 Adjusted Earnings Fall, Revenue Rises - Moomoo
TransMedics Group Q1 Earnings Call Highlights - MarketBeat
TransMedics Q1 2026 slides: revenue growth masks margin pressure By Investing.com - Investing.com South Africa
Transcript : TransMedics Group, Inc., Q1 2026 Earnings Call, May 05, 2026 - marketscreener.com
TransMedics (TMDX) Reports Q1 Earnings: What Key Metrics Have to Say - sharewise.com
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):